About Affimed (AFMD)
Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research t... Read more
- USD0.70
- USD0.72
- USD0.68
- USD8.95
- 9.60%
- 1M
- 93.53k
- 123.56k
- 15M
- 0.52
- -86.90%
Stock News
2 hours ago
FAA weighs reducing Newark flights after hundreds of disruptions
CNBC
2 hours ago
Lutnick says 10% baseline tariff will stick around for "foreseeable future"
CNBC
3 hours ago
The ‘most important consumer earnings report of the season’ lands this week
MarketWatch
3 hours ago
People are feeling lousy about work. The internet's career advice expert has some tips
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
